Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Nov 8, 2025The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Market Cap | Dividend Yield | Payout Ratio | Last Dividend | Annual Dividend | Dividend Percentile | Dividend Dropped Count (L10Y) | Ex-dividend Date | Div. Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|
| PTC | PTC INC | $20.84B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TPR | TAPESTRY INC | $20.22B | 1.47% | 106.60% | $0.4000 | $1.45 | 32% | 1 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $8.15B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| MOG.A | MOOG INC | $6.33B | N/A | 12.80% | $0.2700 | N/A | N/A | 0 | ||
| SGHC | SUPER GROUP (SGHC) LTD | $5.94B | 0.34% | 46.20% | $0.0400 | $0.04 | 5% | 0 | ||
| GTES | GATES INDUSTRIAL CORP PLC | $5.56B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CALX | CALIX INC | $4.27B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| DLO | DLOCAL LTD | $3.99B | 3.86% | 102.90% | $0.5251 | $0.53 | 74% | 0 | ||
| RSI | RUSH STREET INTERACTIVE INC | $3.80B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TPC | TUTOR PERINI CORP | $3.55B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| MIRM | MIRUM PHARMACEUTICALS INC | $3.40B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| FOLD | AMICUS THERAPEUTICS INC | $2.74B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| EXTR | EXTREME NETWORKS INC | $2.34B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| SPNT | SIRIUSPOINT LTD | $2.26B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| IHS | IHS HOLDING LTD | $2.15B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ARDT | ARDENT HEALTH INC | $2.07B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| FIVN | FIVE9 INC | $1.66B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BLBD | BLUE BIRD CORP | $1.60B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BCRX | BIOCRYST PHARMACEUTICALS INC | $1.48B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CRTO | CRITEO SA | $1.18B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| NRDS | NERDWALLET INC | $892.66M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| UDMY | UDEMY INC | $759.70M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TBPH | THERAVANCE BIOPHARMA INC | $748.87M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| LYTS | LSI INDUSTRIES INC | $630.08M | 0.73% | 24.40% | $0.0500 | $0.15 | 16% | 0 | ||
| BWMN | BOWMAN CONSULTING GROUP LTD | $593.85M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| AKBA | AKEBIA THERAPEUTICS INC | $527.90M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| KMDA | KAMADA LTD | $380.68M | 3.02% | 60.60% | $0.2000 | $0.20 | 63% | 0 | ||
| EGHT | 8X8 INC | $268.65M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| NATR | NATURES SUNSHINE PRODUCTS INC | $242.14M | N/A | 0.00% | $1.0000 | N/A | N/A | 0 | ||
| INFU | INFUSYSTEM HOLDINGS INC | $209.26M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CXDO | CREXENDO INC | $207.43M | N/A | 0.00% | $0.0050 | N/A | N/A | 0 | ||
| ELMD | ELECTROMED INC | $203.22M | N/A | 0.00% | N/A | N/A | N/A | N/A |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.